222 related articles for article (PubMed ID: 15877897)
1. Inulin and oligofructose: impact on intestinal diseases and disorders.
Guarner F
Br J Nutr; 2005 Apr; 93 Suppl 1():S61-5. PubMed ID: 15877897
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gut mucosal biofilms.
Kleessen B; Blaut M
Br J Nutr; 2005 Apr; 93 Suppl 1():S35-40. PubMed ID: 15877893
[TBL] [Abstract][Full Text] [Related]
3. Prebiotics in inflammatory bowel diseases.
Guarner F
Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
[TBL] [Abstract][Full Text] [Related]
4. The role of gut-associated lymphoid tissues and mucosal defence.
Forchielli ML; Walker WA
Br J Nutr; 2005 Apr; 93 Suppl 1():S41-8. PubMed ID: 15877894
[TBL] [Abstract][Full Text] [Related]
5. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.
Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA
Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836
[TBL] [Abstract][Full Text] [Related]
6. Inulin, oligofructose and immunomodulation.
Watzl B; Girrbach S; Roller M
Br J Nutr; 2005 Apr; 93 Suppl 1():S49-55. PubMed ID: 15877895
[TBL] [Abstract][Full Text] [Related]
7. Role of inulin as prebiotics on inflammatory bowel disease.
Akram W; Garud N; Joshi R
Drug Discov Ther; 2019; 13(1):1-8. PubMed ID: 30880316
[TBL] [Abstract][Full Text] [Related]
8. Studies with inulin-type fructans on intestinal infections, permeability, and inflammation.
Guarner F
J Nutr; 2007 Nov; 137(11 Suppl):2568S-2571S. PubMed ID: 17951504
[TBL] [Abstract][Full Text] [Related]
9. Application of prebiotics in infant foods.
Veereman-Wauters G
Br J Nutr; 2005 Apr; 93 Suppl 1():S57-60. PubMed ID: 15877896
[TBL] [Abstract][Full Text] [Related]
10. Prebiotics and resistance to gastrointestinal infections.
Gibson GR; McCartney AL; Rastall RA
Br J Nutr; 2005 Apr; 93 Suppl 1():S31-4. PubMed ID: 15877892
[TBL] [Abstract][Full Text] [Related]
11. Introducing inulin-type fructans.
Roberfroid MB
Br J Nutr; 2005 Apr; 93 Suppl 1():S13-25. PubMed ID: 15877886
[TBL] [Abstract][Full Text] [Related]
12. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.
Bosscher D; Breynaert A; Pieters L; Hermans N
J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():5-11. PubMed ID: 20224145
[TBL] [Abstract][Full Text] [Related]
13. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats.
Femia AP; Luceri C; Dolara P; Giannini A; Biggeri A; Salvadori M; Clune Y; Collins KJ; Paglierani M; Caderni G
Carcinogenesis; 2002 Nov; 23(11):1953-60. PubMed ID: 12419846
[TBL] [Abstract][Full Text] [Related]
14. The SYNCAN project: goals, set-up, first results and settings of the human intervention study.
Van Loo J; Clune Y; Bennett M; Collins JK
Br J Nutr; 2005 Apr; 93 Suppl 1():S91-8. PubMed ID: 15877901
[TBL] [Abstract][Full Text] [Related]
15. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease.
Hedin CR; McCarthy NE; Louis P; Farquharson FM; McCartney S; Stagg AJ; Lindsay JO; Whelan K
Clin Nutr; 2021 Aug; 40(8):5009-5019. PubMed ID: 34364241
[TBL] [Abstract][Full Text] [Related]
16. Mucosal bacteria in ulcerative colitis.
Macfarlane S; Furrie E; Kennedy A; Cummings JH; Macfarlane GT
Br J Nutr; 2005 Apr; 93 Suppl 1():S67-72. PubMed ID: 15877898
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth.
Reddy BS
J Nutr; 1999 Jul; 129(7 Suppl):1478S-82S. PubMed ID: 10395625
[TBL] [Abstract][Full Text] [Related]
18. Inulin and oligofructose in the dietary fibre concept.
Cherbut C
Br J Nutr; 2002 May; 87 Suppl 2():S159-62. PubMed ID: 12088513
[TBL] [Abstract][Full Text] [Related]
19. Prebiotic effects of inulin and oligofructose.
Kolida S; Tuohy K; Gibson GR
Br J Nutr; 2002 May; 87 Suppl 2():S193-7. PubMed ID: 12088518
[TBL] [Abstract][Full Text] [Related]
20. Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial.
Majid HA; Cole J; Emery PW; Whelan K
Clin Nutr; 2014 Dec; 33(6):966-72. PubMed ID: 24290345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
